MTOR and cancer: mTOR is often dysregulated in human cancers, and somatic mutations that induce mTOR activation have recently been identified in several types of human cancers, suggesting that mTOR is a therapeutic target (Murugan, 2019; Huang, 2020; Zou et al., 2020).